MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Dev Growth Differ. 2018 Jan;60(1):21-32. doi: 10.1111/dgd.12420. Epub 2018 Jan 24.
Inherited mutations in the mitochondrial (mt)DNA are a major cause of human disease, with approximately 1 in 5000 people affected by one of the hundreds of identified pathogenic mtDNA point mutations or deletions. Due to the severe, and often untreatable, symptoms of many mitochondrial diseases, identifying how these mutations are inherited from one generation to the next has been an area of intense research in recent years. Despite large advances in our understanding of this complex process, many questions remain unanswered, with one of the most hotly debated being whether or not purifying selection acts against pathogenic mutations during germline development.
线粒体(mt)DNA 中的遗传突变是人类疾病的主要原因,大约每 5000 人中就有 1 人受到数百种已确定的致病性 mtDNA 点突变或缺失之一的影响。由于许多线粒体疾病的症状严重且往往无法治疗,因此确定这些突变如何从一代遗传到下一代一直是近年来研究的热点领域。尽管我们在理解这个复杂过程方面取得了很大进展,但仍有许多问题尚未得到解答,其中最具争议的问题之一是在生殖系发育过程中是否存在净化选择来对抗致病性突变。